Insight into the functional consequences of hMYH variants associated with colorectal cancer

Distinct differences in the adenine glycosylase activity and the response to AP endonucleases of Y150C and G365D murine MYH

Mary Ann Pope, Nikolas H. Chmiel, Sheila S. David

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Escherichia coli MutY and its eukaryotic homologues play an important role in preventing mutations by removing adenine from 7,8-dihydro-8-oxo-2′- deoxyguanosine (OG):A mismatches. It has recently been demonstrated that inherited biallelic mutations in the genes encoding the human homologue of MutY (hMYH) are correlated with a genetic predisposition for multiple colorectal adenomas and carcinomas. The two most common hMYH variants found in patients with colorectal cancer are Y165C and G382D. In this study, we examined the equivalent variants in the murine MutY homologue (mMYH), Y150C and G365D. The Y150C mMYH enzyme showed a large decrease in the rate of adenine removal from both OG:A- and G:A-containing substrates, while G365D mMYH showed a decrease in the ability to catalyze adenine removal only with a G:A-containing substrate. Both mMYH variants exhibit a significantly decreased affinity for duplexes containing noncleavable 2′-deoxyadenosine analogues. In addition, the human apurinic/apyrimidinic endonuclease (Ape1) stimulated product formation by wild-type and G365D mMYH with an OG:A substrate under conditions of multiple-turnover ([E] < [S]). In contrast, the presence of Ape1 nearly completely inhibited adenine removal by Y150C mMYH from the OG:A mismatch substrate. The more deleterious effect of Ape1 on the glycosylase activity of Y150C relative to G365D mMYH correlated with the more compromised binding affinity of Y150C to substrate analogue duplexes. These results suggest that the equivalent hMYH variants may be significantly compromised in substrate targeting in vivo due to a decrease in binding to substrate DNA; moreover, competition with other DNA binding proteins may further reduce the effective adenine glycosylase activity in vivo.

Original languageEnglish (US)
Pages (from-to)315-325
Number of pages11
JournalDNA Repair
Volume4
Issue number3
DOIs
StatePublished - Mar 2 2005
Externally publishedYes

Fingerprint

DNA-(Apurinic or Apyrimidinic Site) Lyase
Adenine
Colorectal Neoplasms
Substrates
Mutation
DNA-Binding Proteins
Genetic Predisposition to Disease
Adenoma
Gene encoding
Escherichia coli
Endonucleases
adenine glycosylase
DNA
Enzymes
Genes

Keywords

  • 8-Oxoguanine
  • Adenine glycosylase
  • Base excision repair
  • Colorectal cancer
  • MYH-associated polyposis

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Insight into the functional consequences of hMYH variants associated with colorectal cancer : Distinct differences in the adenine glycosylase activity and the response to AP endonucleases of Y150C and G365D murine MYH. / Pope, Mary Ann; Chmiel, Nikolas H.; David, Sheila S.

In: DNA Repair, Vol. 4, No. 3, 02.03.2005, p. 315-325.

Research output: Contribution to journalArticle

@article{168fcb3fb451440e8006a8f72affc42c,
title = "Insight into the functional consequences of hMYH variants associated with colorectal cancer: Distinct differences in the adenine glycosylase activity and the response to AP endonucleases of Y150C and G365D murine MYH",
abstract = "Escherichia coli MutY and its eukaryotic homologues play an important role in preventing mutations by removing adenine from 7,8-dihydro-8-oxo-2′- deoxyguanosine (OG):A mismatches. It has recently been demonstrated that inherited biallelic mutations in the genes encoding the human homologue of MutY (hMYH) are correlated with a genetic predisposition for multiple colorectal adenomas and carcinomas. The two most common hMYH variants found in patients with colorectal cancer are Y165C and G382D. In this study, we examined the equivalent variants in the murine MutY homologue (mMYH), Y150C and G365D. The Y150C mMYH enzyme showed a large decrease in the rate of adenine removal from both OG:A- and G:A-containing substrates, while G365D mMYH showed a decrease in the ability to catalyze adenine removal only with a G:A-containing substrate. Both mMYH variants exhibit a significantly decreased affinity for duplexes containing noncleavable 2′-deoxyadenosine analogues. In addition, the human apurinic/apyrimidinic endonuclease (Ape1) stimulated product formation by wild-type and G365D mMYH with an OG:A substrate under conditions of multiple-turnover ([E] < [S]). In contrast, the presence of Ape1 nearly completely inhibited adenine removal by Y150C mMYH from the OG:A mismatch substrate. The more deleterious effect of Ape1 on the glycosylase activity of Y150C relative to G365D mMYH correlated with the more compromised binding affinity of Y150C to substrate analogue duplexes. These results suggest that the equivalent hMYH variants may be significantly compromised in substrate targeting in vivo due to a decrease in binding to substrate DNA; moreover, competition with other DNA binding proteins may further reduce the effective adenine glycosylase activity in vivo.",
keywords = "8-Oxoguanine, Adenine glycosylase, Base excision repair, Colorectal cancer, MYH-associated polyposis",
author = "Pope, {Mary Ann} and Chmiel, {Nikolas H.} and David, {Sheila S.}",
year = "2005",
month = "3",
day = "2",
doi = "10.1016/j.dnarep.2004.10.003",
language = "English (US)",
volume = "4",
pages = "315--325",
journal = "DNA Repair",
issn = "1568-7864",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Insight into the functional consequences of hMYH variants associated with colorectal cancer

T2 - Distinct differences in the adenine glycosylase activity and the response to AP endonucleases of Y150C and G365D murine MYH

AU - Pope, Mary Ann

AU - Chmiel, Nikolas H.

AU - David, Sheila S.

PY - 2005/3/2

Y1 - 2005/3/2

N2 - Escherichia coli MutY and its eukaryotic homologues play an important role in preventing mutations by removing adenine from 7,8-dihydro-8-oxo-2′- deoxyguanosine (OG):A mismatches. It has recently been demonstrated that inherited biallelic mutations in the genes encoding the human homologue of MutY (hMYH) are correlated with a genetic predisposition for multiple colorectal adenomas and carcinomas. The two most common hMYH variants found in patients with colorectal cancer are Y165C and G382D. In this study, we examined the equivalent variants in the murine MutY homologue (mMYH), Y150C and G365D. The Y150C mMYH enzyme showed a large decrease in the rate of adenine removal from both OG:A- and G:A-containing substrates, while G365D mMYH showed a decrease in the ability to catalyze adenine removal only with a G:A-containing substrate. Both mMYH variants exhibit a significantly decreased affinity for duplexes containing noncleavable 2′-deoxyadenosine analogues. In addition, the human apurinic/apyrimidinic endonuclease (Ape1) stimulated product formation by wild-type and G365D mMYH with an OG:A substrate under conditions of multiple-turnover ([E] < [S]). In contrast, the presence of Ape1 nearly completely inhibited adenine removal by Y150C mMYH from the OG:A mismatch substrate. The more deleterious effect of Ape1 on the glycosylase activity of Y150C relative to G365D mMYH correlated with the more compromised binding affinity of Y150C to substrate analogue duplexes. These results suggest that the equivalent hMYH variants may be significantly compromised in substrate targeting in vivo due to a decrease in binding to substrate DNA; moreover, competition with other DNA binding proteins may further reduce the effective adenine glycosylase activity in vivo.

AB - Escherichia coli MutY and its eukaryotic homologues play an important role in preventing mutations by removing adenine from 7,8-dihydro-8-oxo-2′- deoxyguanosine (OG):A mismatches. It has recently been demonstrated that inherited biallelic mutations in the genes encoding the human homologue of MutY (hMYH) are correlated with a genetic predisposition for multiple colorectal adenomas and carcinomas. The two most common hMYH variants found in patients with colorectal cancer are Y165C and G382D. In this study, we examined the equivalent variants in the murine MutY homologue (mMYH), Y150C and G365D. The Y150C mMYH enzyme showed a large decrease in the rate of adenine removal from both OG:A- and G:A-containing substrates, while G365D mMYH showed a decrease in the ability to catalyze adenine removal only with a G:A-containing substrate. Both mMYH variants exhibit a significantly decreased affinity for duplexes containing noncleavable 2′-deoxyadenosine analogues. In addition, the human apurinic/apyrimidinic endonuclease (Ape1) stimulated product formation by wild-type and G365D mMYH with an OG:A substrate under conditions of multiple-turnover ([E] < [S]). In contrast, the presence of Ape1 nearly completely inhibited adenine removal by Y150C mMYH from the OG:A mismatch substrate. The more deleterious effect of Ape1 on the glycosylase activity of Y150C relative to G365D mMYH correlated with the more compromised binding affinity of Y150C to substrate analogue duplexes. These results suggest that the equivalent hMYH variants may be significantly compromised in substrate targeting in vivo due to a decrease in binding to substrate DNA; moreover, competition with other DNA binding proteins may further reduce the effective adenine glycosylase activity in vivo.

KW - 8-Oxoguanine

KW - Adenine glycosylase

KW - Base excision repair

KW - Colorectal cancer

KW - MYH-associated polyposis

UR - http://www.scopus.com/inward/record.url?scp=12344258702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12344258702&partnerID=8YFLogxK

U2 - 10.1016/j.dnarep.2004.10.003

DO - 10.1016/j.dnarep.2004.10.003

M3 - Article

VL - 4

SP - 315

EP - 325

JO - DNA Repair

JF - DNA Repair

SN - 1568-7864

IS - 3

ER -